Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Kaplan M. A., Isikdogan A., Koca D., KÜÇÜKÖNER M., Gumusay O., Yildiz R., ...More

BREAST CANCER, vol.21, no.6, pp.677-683, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 6
  • Publication Date: 2014
  • Doi Number: 10.1007/s12282-013-0441-y
  • Journal Name: BREAST CANCER
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.677-683
  • Keywords: Lapatinib, Capecitabine, Trastuzumab, Brain metastases, Breast cancer, HER2, HER2
  • Gazi University Affiliated: Yes


In this study, we investigated the effect of lapatinib plus capecitabine treatment in HER2-positive breast cancer patients with brain metastasis.